课题基金 / 基金详情

Impairment of the dimer formation of interferon regulatory factor-3 by hepatitis C virus core protein leads to evade interferon system

Impairment of the dimer formation of interferon regulatory factor-3 by hepatitis C virus core protein leads to evade interferon system
丙型肝炎病毒核心蛋白损害干扰素调节因子3二聚体形成导致逃避干扰素系统
批准号:
14370106
负责人:
KOHARA Michinori
金额:
$8.9万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

KOHARA Michinori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the prominent features of hepatitis C virus (HCV) is persistent infection, which is assumed to be a crucial event as a result of evading host defense system. Type I interferon beta (IFN-β) system is induced rapidly after viral infection and plays a central role in innate immunity. Upon immediate induction of type I IFN as host first defense line, interferon regulatory factor-3 (IRF-3) is phosphorylated, formed of homodimer and translocates to nucleus. IFN-β induction due to new castle disease virus (NDV) was significantly decreased after the expression of full HCV genome (HCR6-Rz). Similar modification was observed in cell line expressing core to the NS2 protein region (HCR6-Fse). However, this decreasing was not observed in cell line expressing NS2 to the NS5B region (HCR6-Age). IRF-3 dimer formation induced by NDV infection was also suppressed after the expression of HCR6-Rz and HCR6-Fse, but not HCR6-Age. We further analyzed using transiently expressed HCV core, E1 or E2 in HepG2 cells. The suppression of IRF-3 dimer formation was caused by HCV core protein alone. These results indicated that a new crucial biological function of HCV core protein that may be related to persistence and pathogenesis of HCV.
期刊论文(58)
专著(0)
科研奖励(0)
会议论文
小原 道法: "肝炎ウイルス感染モデル.ヒト型モデル動物"シュプリンガー・フェアラーク. 46-52 (2002)
Michiho Ohara:“肝炎病毒感染模型。人类模型动物”Springer-Verlag 46-52 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mizukawa, Y.: "Direct evidence for IFN-g production by effector memory CD8^+ T cells residing at an effector site of pathology in fixed drug eruption : A model for epidermal injury mediated by skin resident T cells"J. Amer. Patho.. 161. 1337-1347 (2002)
Mizukawa, Y.:“固定药疹病理学效应位点上的效应记忆 CD8^ T 细胞产生 IFN-g 的直接证据:皮肤驻留 T 细胞介导的表皮损伤模型”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Maeda, N.: "Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone."Liver International. (in press). (2004)
Maeda, N.:“移植到具有感染性分子克隆的小鼠体内的人类肝组织中发生丙型肝炎病毒感染。”肝脏国际。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takaku, S.: "Induction of hepatic injury by HCV structural protein-specific CD8^+ class I MHC molecule-restricted murine CTLs in transgenic mice expressing the HCV structural genes."Biochem.Biophys.Res.Commun.. 301. 330-337 (2003)
Takaku, S.:“在表达 HCV 结构基因的转基因小鼠中,HCV 结构蛋白特异性 CD8^ I 类 MHC 分子限制性小鼠 CTL 诱导肝损伤。”Biochem.Biophys.Res.Commun. 301. 330-337
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
17
    Pathology of spontaneous breast tumor in tree shrews (Tupaia belangeri chinenesis)
    Macrocycles to target influenza viral hemagglutinin as bifunctional potent broad-spectrum antiviral agent
    iHA-100 exhibited a high efficacy whether administered during the early phase or late phase of H5N1 infection
    Influenza viral hemagglutinin-targeted macrocyclic peptides as an antiviral agent
    国内基金
    海外基金
    系统性探索不同N-glycan修饰对Interferonβ活性和稳定性影响
    • 批准号:
      21877063
    • 项目类别:
      面上项目
    • 资助金额:
      61.4万元
    • 批准年份:
      2018
    • 负责人:
      王鹏
    • 依托单位:
    糖药物蛋白Interferonβ N-glycan的均一、人源化改造
    • 批准号:
      81102361
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2011
    • 负责人:
      程剑松
    • 依托单位: